Aandeel BMY BRISTOL-MYERS SQUIBB COMPANY
Toevoegen aan een lijst

Bedrijfsvoering Bristol-Myers Squibb Company

Aandelen

BMY

US1101221083

Farmaceutische producten

Beurs gesloten - Nyse
Andere beurzen
 22:00:02 13-02-2026 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
60,74 USD +1,47% Intraday-grafiek van Bristol-Myers Squibb Company -2,02% +12,61%
09/02 Evinova van AstraZeneca sluit AI-partnerschap voor klinische ontwikkeling MT
06/02 BRISTOL-MYERS SQUIBB COMPANY : Morgan Stanley handhaaft het verkoopadvies ZM

Uitvoerend comité: Bristol-Myers Squibb Company

Bedrijfsleider
Beklede functiesVan
Christopher Boerner

Christopher Boerner

55 jaar

Chief Executive Officer 01-11-2023
Phil Holzer

Phil Holzer

50 jaar

Comptroller/Controller/Auditor 01-01-2015
Robert Plenge

Robert Plenge

55 jaar

Chief Tech/Sci/R&D Officer 01-11-2019
Estelle Vester-Blokland

Estelle Vester-Blokland

Chief Tech/Sci/R&D Officer -
Catalina Vargas

Catalina Vargas

Human Resources Officer -
Greg Meyers

Greg Meyers

53 jaar

Chief Tech/Sci/R&D Officer -
Cari Gallman

Cari Gallman

46 jaar

General Counsel 05-05-2025
Kimberly McCutcheon Jablonski

Kimberly McCutcheon Jablonski

Compliance Officer 01-10-2023
David Elkins

David Elkins

58 jaar

Director of Finance/CFO 20-11-2019

Samenstelling van de raad van bestuur: Bristol-Myers Squibb Company

Directeur
RadenVan
Christopher Boerner

Christopher Boerner

55 jaar

Chairman 01-04-2024
Theodore Samuels

Theodore Samuels

71 jaar

Audit Committee 21-02-2017
Governance Committee Chair 17-07-2023
Compensation Committee 01-01-2022
Governance Committee 01-01-2022
Finance Committee 17-07-2023
Nominating Committee Chair 17-07-2023
Paula Price

Paula Price

64 jaar

Compensation Committee 09-05-2014
HR Committee 09-05-2014
Audit Committee Chair 01-01-2022
Audit Committee
Governance Committee
Phyllis Yale

Phyllis Yale

68 jaar

Governance Committee Chair 11-07-2016
Nominating Committee Chair 11-07-2016
Audit Committee
Governance Committee 05-12-2019
Derica Rice

Derica Rice

61 jaar

Audit Committee Chair
Compensation Committee
Audit Committee 22-07-2021
Finance Committee 31-08-2020
Michael McMullen

Michael McMullen

65 jaar

HR Committee 24-07-2023
Compensation Committee Chair 05-11-2025
Audit Committee 01-07-2024
Julia Haller

Julia Haller

71 jaar

Governance Committee 11-08-2022
Nominating Committee 11-08-2022
Manuel Medina

Manuel Medina

58 jaar

Governance Committee 17-07-2024
Nominating Committee 17-07-2024
Karen Vousden

Karen Vousden

68 jaar

Compensation Committee 01-01-2018
Deepak Bhatt

Deepak Bhatt

58 jaar

Compensation Committee 14-06-2022
Peter Arduini

Peter Arduini

61 jaar

Compensation Committee Chair

Recente benoemingen: Bristol-Myers Squibb Company

30/01 Moderna, Inc. kondigt wijzigingen aan in directie en commissies, met ingang van 2 maart 2026 CI
30/01 Moderna CMO Jacqueline Miller treedt af RE
12/01 BioXcel Therapeutics, Inc. benoemt Mark Pavao tot waarnemend Chief Commercial Officer en zal de ontwikkeling en uitvoering van de commerciële plannen van het bedrijf leiden CI
12/01 Zymeworks Inc. kondigt wijzigingen in het managementteam aan CI
16/12 KORU Medical Systems, Inc. benoemt Eric Schiller tot Chief Technology Officer, met ingang van 29 december 2025 CI
15/12 ImmunityBio, Inc. benoemt Bruce Wendel tot lid van de raad van bestuur, met ingang van 12 december 2025 CI
17/11 Mesoblast benoemt James O'Brien tot CFO MT
Meer nieuws

Voormalige zaakvoerders en bestuurders: Bristol-Myers Squibb Company

Insider
Beklede functies
VanTot
Sandra Leung
Sandra Leung
General Counsel 01-01-2007 05-05-2025
Corporate Secretary 01-01-2007 01-01-2015
Vicki Sato
Vicki Sato
Director/Board Member 11-07-2006 04-05-2021
Independent Dir/Board Member 11-07-2006 04-05-2021
Michael Grobstein
Michael Grobstein
Director/Board Member 06-03-2007 05-05-2020
Independent Dir/Board Member 06-03-2007 05-05-2020
John E. Elicker
John E. Elicker
Investor Relations Contact 01-01-2000 31-03-2020
Public Communications Contact 01-01-2000 06-01-2020
Joseph C. Caldarella
Joseph C. Caldarella
Comptroller/Controller/Auditor 01-01-2010 15-02-2018
Laurie Glimcher
Laurie Glimcher
Director/Board Member 01-01-1997 21-07-2017
Independent Dir/Board Member 01-01-1997 21-07-2017
Lamberto Andreotti
Lamberto Andreotti
Director/Board Member 01-01-2009 01-01-2015
Chief Executive Officer 04-05-2010 05-05-2015
Chairman 01-01-2015 02-05-2017
Chief Operating Officer 01-05-2008 01-05-2010
Corporate Officer/Principal 01-01-1998 01-05-2008
James Cornelius
James Cornelius
Chief Executive Officer 12-09-2006 04-05-2010
Chairman 01-09-2006 05-05-2015
Independent Dir/Board Member 01-01-2005 05-05-2015
President 01-09-2006 14-02-2013
John E. Celentano
John E. Celentano
Human Resources Officer 13-05-2011 08-10-2012
Public Communications Contact 13-05-2011 08-10-2012
Corporate Officer/Principal 01-01-2000 01-07-2013
Charles Sigal
Charles Sigal
Director/Board Member 03-03-2011 01-06-2013
Chief Tech/Sci/R&D Officer 01-10-2004 01-06-2013
Robert Williams
Robert Williams
Director/Board Member 11-09-2006 31-05-2013
Independent Dir/Board Member 12-05-2011 31-05-2013
Louis J. Freeh
Louis J. Freeh
Director/Board Member 01-01-2005 07-03-2013
Independent Dir/Board Member 11-05-2011 07-03-2013
Anthony Hooper
Anthony Hooper
Chief Operating Officer 13-05-2011 20-10-2011
Corporate Officer/Principal 01-01-1996 13-05-2011
Leif Valdemar Johansson
Leif Valdemar Johansson
Director/Board Member 01-01-1998 20-09-2011
Independent Dir/Board Member 11-05-2011 20-09-2011
Carlo de Notaristefani
Carlo de Notaristefani
Corporate Officer/Principal 01-01-2004 01-07-2011
Blaine Davis
Blaine Davis
Corporate Officer/Principal 01-01-2005 01-05-2008
Stephen E. Bear
Stephen E. Bear
Human Resources Officer 01-01-2001 31-03-2008
Richard K. Willard
Richard K. Willard
General Counsel 01-01-2005 11-05-2007
Andrew Bonfield
Andrew Bonfield
Director of Finance/CFO 01-01-2002 01-01-2007
David J. Helfgott
David J. Helfgott
Chief Operating Officer 15-11-2006 -
President 15-11-2006 -
Louis Sullivan
Louis Sullivan
Director/Board Member - 02-05-2006
Louis Gerstner
Louis Gerstner
Director/Board Member - 02-05-2006
Independent Dir/Board Member - 02-05-2006
Donald Hayden
Donald Hayden
Corporate Officer/Principal 01-01-1981 01-01-2006
John L. McGoldrick
John L. McGoldrick
General Counsel 01-01-1995 01-10-2005
Robert T. Zito
Robert T. Zito
Public Communications Contact 01-06-2004 -
Dean Mitchell
Dean Mitchell
Corporate Officer/Principal 01-01-2001 01-01-2004
Edward M. Dwyer
Edward M. Dwyer
Treasurer 01-01-2004 -
Juan Sanchez
Juan Sanchez
Corporate Officer/Principal - 01-11-2003
Carol Marino
Carol Marino
Corporate Officer/Principal 01-09-1995 01-01-2003
Richard L. Wolgemuth
Richard L. Wolgemuth
General Counsel 01-01-2003 -
Fabio M. Benedetti
Fabio M. Benedetti
Chief Tech/Sci/R&D Officer 01-07-1999 01-05-2002
Steven E. Benner
Steven E. Benner
Chief Tech/Sci/R&D Officer 01-01-1995 01-01-2002
Stacey M. Lituchy
Stacey M. Lituchy
Corporate Officer/Principal - 31-12-2001
Gary Dickinson
Gary Dickinson
Human Resources Officer 01-01-1997 01-04-2001
David L. Zabor
David L. Zabor
Corporate Officer/Principal 01-01-2001 -
Stacey Latuche
Stacey Latuche
Portfolio Manager-Equities - 31-12-2000
Ronald Pepin
Ronald Pepin
Chief Tech/Sci/R&D Officer 01-03-1990 01-07-2000
Jaisim Shah
Jaisim Shah
Sales & Marketing 01-07-1997 01-07-2000
Robert L. Simon
Robert L. Simon
General Counsel 01-01-1987 01-07-2000
Myrtle Potter
Myrtle Potter
Corporate Officer/Principal 01-01-1996 01-05-2000
Andrew Bodnar
Andrew Bodnar
Chief Tech/Sci/R&D Officer 01-01-2000 -
Kin Yip Leung
Kin Yip Leung
Corporate Officer/Principal 01-01-1990 01-02-1999
Nicole Onetto
Nicole Onetto
Chief Tech/Sci/R&D Officer 01-07-1991 01-05-1997
Kenneth Anderson
Kenneth Anderson
Sales & Marketing 01-01-1980 01-01-1997
Joachim von Roy
Joachim von Roy
Corporate Officer/Principal - 01-01-1997
William Scott
William Scott
Corporate Officer/Principal 01-01-1990 31-12-1996
N. Coles
N. Coles
Corporate Officer/Principal 01-01-1996 -
Robert B. Ross
Robert B. Ross
Corporate Officer/Principal 01-01-1991 31-12-1994
Patrick J. Fortune
Patrick J. Fortune
Corporate Officer/Principal 01-12-1991 01-08-1994
Mark J. Carvlin
Mark J. Carvlin
Sales & Marketing 01-01-1989 31-12-1993
Lawrence Hamilton
Lawrence Hamilton
Chief Administrative Officer 01-01-1985 01-08-1993
Human Resources Officer 01-01-1985 01-08-1993
Barry Wilson
Barry Wilson
Corporate Officer/Principal 01-01-1980 01-01-1993
Henry Y. Pan
Henry Y. Pan
Corporate Officer/Principal 01-01-1985 01-01-1992
Steven Ratoff
Steven Ratoff
Director of Finance/CFO 01-01-1975 01-01-1991
Corporate Officer/Principal 01-01-1975 -
George Zavoico
George Zavoico
Corporate Officer/Principal 01-01-1988 -
Robert A. Fildes
Robert A. Fildes
Chief Operating Officer 01-01-1975 01-01-1980
Jerry Frantz
Jerry Frantz
Sales & Marketing - -
Steven Girgenti
Steven Girgenti
Corporate Officer/Principal - -
Alexander MacPherson
Alexander MacPherson
Corporate Officer/Principal - -
Salvatore Forenz
Salvatore Forenz
Director/Board Member - -
Lori A. Klimach
Lori A. Klimach
Sales & Marketing - -
Mark Gleason
Mark Gleason
Corporate Officer/Principal - -
Andrew P. Savadelis
Andrew P. Savadelis
Treasurer - -
James A. McClintic
James A. McClintic
Sales & Marketing - -
Guo Wei Wang
Guo Wei Wang
Corporate Officer/Principal - -
Arthur C. Louie
Arthur C. Louie
Corporate Officer/Principal - -
Anthony Plohoros
Anthony Plohoros
Public Communications Contact - -
John L. Skule
John L. Skule
Public Communications Contact - -
Paul Karr
Paul Karr
Comptroller/Controller/Auditor - -
Andrew Forman
Andrew Forman
Corporate Officer/Principal - -
Greg W. Cashman
Greg W. Cashman
Director of Finance/CFO - 31-12-1995
Ronald Thiboutot
Ronald Thiboutot
Corporate Officer/Principal - -
Jay Moorin
Jay Moorin
Corporate Officer/Principal - -
Jonas Wang
Jonas Wang
Corporate Officer/Principal - -
James B. Palmer
James B. Palmer
Chief Tech/Sci/R&D Officer - -
President - -
H. Perry Fell
H. Perry Fell
Corporate Officer/Principal - -

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man22
Vrouw8

Waarvan leden van het uitvoerend comité

Man5
Vrouw4

Waarvan bestuurders

Man9
Vrouw2

Herzieningen

Révisions CA 1 an
Révisions CA 4 mois
Révisions CA 1 mois
Révisions BNA 1 an
Révisions BNA 4 mois
ESG MSCI

ESG MSCI

Environnement
Social
Gouvernance
Polémique
Controverses Ethiques
Nee
Controverses sur les droits de l'Homme
Nee
Controverses Subventions fiscales
Ja
Conforme à la finance Islamique
Nee

Bedrijfsprofiel

Logo Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is gespecialiseerd in de ontwikkeling, de vervaardiging en de verkoop van farmaceutische producten. De producten zijn bestemd voor de behandeling van kanker, hart- en vaatziektes, hepatitis, immuunziektes en psychiatrische stoornissen. 69,1% van de omzet wordt gemaakt in de Verenigde Staten.
Werknemers
34.100
Sector
Farmaceutische producten
Agenda
30/04 - Q1 2026 Cijferpublicaties
Meer informatie over het bedrijf

Sleutelfiguren die het bedrijf verlieten

Giovanni Caforio
-
Giovanni Caforio

Chief Executive Officer

05-05-2015 01-11-2023

Lamberto Andreotti
-
Lamberto Andreotti

Chief Executive Officer

04-05-2010 05-05-2015

James Cornelius
-
James Cornelius

Chief Executive Officer

12-09-2006 04-05-2010

James Robinson
-
James Robinson

Chairman

01-01-2005 01-05-2008

Peter R. Dolan
-
Peter R. Dolan

Chief Executive Officer

08-02-2001 12-09-2006

Charles A. Heimbold
-
Charles A. Heimbold

Chief Executive Officer

01-01-1994 31-12-2001

  1. Beurs
  2. Aandelen
  3. Koers BMY
  4. Onderneming Bristol-Myers Squibb Company
  5. Bedrijfsvoering

Kies jouw editie

Alle financiële informatie op nationaal niveau

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
Verenigde Staten

MarketScreener is also available in this country: United States.

Switch edition
Ik blijf hier.